Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Meeting Results* for: March 4, 2009

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Sancuso	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Moxatag	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Astepro	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Trilipix	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Stavzor	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Janumet	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Required
Banzel	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Tekturna HCT	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Letairis	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Megace ES	New Drug Appeal	Require Prior Approval	Prior Approval Required
Bystolic	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Pristiq	New Drug Appeal	Require Prior Approval	Prior Approval Required
Keppra XR	New Drug Appeal	Require Prior Approval	Prior Approval Required
Exforge	New Drug Appeal	Require Prior Approval	Prior Approval Required
Tekturna	New Drug Appeal	Require Prior Approval	Prior Approval Required

Footer